Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berg

Showing results (651-660 of 668) with videos related to

Pageof 67
Sort By:
JCO Precision Oncology|June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialKieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
JCO Precision Oncology|September 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621DTheodore W Laetsch, Kathleen Ludwig, P Mickey Williams, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialD Williams Parsons, Katherine A Janeway, David R Patton, et al.
Journal of the National Cancer Institute|May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CSusan N Chi, Joanna S Yi, P Mickey Williams, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2012
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionNorah A Terrault, Michelle E Roland, Thomas Schiano, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2024
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus costQimeng Gao, Isaac S Alderete, Nihal Aykun, et al.
Genetic Epidemiology|May 19, 2015
Biology-Driven Gene-Gene Interaction Analysis of Age-Related Cataract in the eMERGE NetworkMolly A Hall, Shefali S Verma, John Wallace, et al.
The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.
Molecular Vision|October 30, 2014
Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility lociMarylyn D Ritchie, Shefali S Verma, Molly A Hall, et al.
Pageof 67

Showing results (651-660 of 668) with videos related to

Sort By:
Pageof 67
JCO Precision Oncology|June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialKieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
JCO Precision Oncology|September 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621DTheodore W Laetsch, Kathleen Ludwig, P Mickey Williams, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialD Williams Parsons, Katherine A Janeway, David R Patton, et al.
Journal of the National Cancer Institute|May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CSusan N Chi, Joanna S Yi, P Mickey Williams, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2012
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionNorah A Terrault, Michelle E Roland, Thomas Schiano, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2024
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus costQimeng Gao, Isaac S Alderete, Nihal Aykun, et al.
Genetic Epidemiology|May 19, 2015
Biology-Driven Gene-Gene Interaction Analysis of Age-Related Cataract in the eMERGE NetworkMolly A Hall, Shefali S Verma, John Wallace, et al.
The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.
Molecular Vision|October 30, 2014
Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility lociMarylyn D Ritchie, Shefali S Verma, Molly A Hall, et al.
Pageof 67